Contraception News and Research

Latest Contraception News and Research

Supreme Court to hear arguments on health law's contraceptive coverage mandate

The justices accepted a pair of cases that raise questions not just about religious freedom and equality for female employees, but whether the religious beliefs of the owners of secular corporations allows them to not comply with a law.

27 Nov 2013

First Edition: Nov. 27, 2013

Kaiser Health News staff writer Phil Galewitz, in collaboration with McClatchy, reports: "Like half the states, South Carolina chose not to expand Medicaid under the federal health law next year, citing the program's high costs and inefficiency. Yet, state officials still forecast a 16 percent enrollment jump by the end of June, 2015, triple that of a typical year and even higher than the 12 percent average increase expected in states that are expanding eligibility.

27 Nov 2013

Supreme Court mulls taking health law contraception case

The justices could announce as early as Tuesday whether they will review provisions in the Affordable Care Act requiring employers of a certain size to offer insurance coverage for birth control and other reproductive health services without a co-pay. The owners of more than three dozen for-profit companies have argued that complying with that provision would violate their religious beliefs.

27 Nov 2013

UT Austin study reveals gender differences in sexual regret

In the largest, most in-depth study to date on regret surrounding sexual activity, a team of psychology researchers found a stark contrast in remorse between men and women, potentially shedding light on the evolutionary history of human nature.

26 Nov 2013

Contraception coverage, abortion loom as issues for high court and advocacy groups

Advocacy groups are wondering about a future boomerang affect of the "nuclear option," which could keep Senate Republicans from filibustering judicial nominations.

20 Nov 2013

Gilead Sciences gets marketing authorization from European Commission for Vitekta tablets

Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Vitekta (elvitegravir 85 mg and 150 mg) tablets, an integrase inhibitor for the treatment of HIV-1 infection in adults without known mutations associated with resistance to elvitegravir.

18 Nov 2013

Viewpoints: Some who supported health law learning first-hand about the downsides; small businesses not finding better deals; Clinton should know there is no 'magic solution'

Margaret Davis of West L.A. voted for President Obama and appreciates the ideas behind the Affordable Care Act. She agrees that everyone should have access to healthcare and no one should be denied coverage because of pre-existing conditions. But here's the problem: She knows firsthand, as the new law of the land rolls clumsily into being, that it's not working out to everyone's advantage (Steve Lopez, 11/12).

14 Nov 2013

In states not expanding Medicaid, hospitals face a squeeze as federal funds dry up

The New York Times examines the dilemma for some safety-net hospitals that will not see a drop in the uninsured but will lose federal money that used to help pay for those patients.

12 Nov 2013

First Edition: November 11, 2013

Today's headlines include reports about how Republicans are positioning themselves to capitalize on the health law's implementation difficulties in the upcoming election season.

11 Nov 2013

Viewpoints: Campaigning won't help solve health care problems; health law sought 'sturdier safety net;' court's decision on contraception benefit 'goes wrong way'

The Obamacare Web site doesn't work. Hundreds of thousands of insured Americans are seeing their plans summarily terminated. Millions more face the same prospect next year. Confronted with a crisis of governance, how does President Obama respond? He campaigns (Charles Krauthammer, 11/7).

11 Nov 2013

New study looks at hormone/SNS relationship in women taking hormone contraceptives

After menopause, women's levels of estrogen and progesterone fall. Their formerly lower risk for heart disease equals, even surpasses, men's risk. One possible contributing explanation for the change in risk is that sex hormones affect the sympathetic nervous system, which controls constriction of blood vessels and participates in the fight or flight response.

7 Nov 2013

Appeals court decision is latest blow to birth control mandate, setting up possible Supreme Court consideration

A divided federal appeals court on Friday ruled against the health law's requirement that businesses with 50 or more workers cover birth control in employee health plans.

5 Nov 2013

First Edition: November 4, 2013

Today's headlines include the latest on the efforts to address the problems with healthcare.gov, as well as the continuing controversy surrounding President Barack Obama's promise that Americans could keep their health coverage if they liked it juxtaposed with the news of recent policy cancellations.

4 Nov 2013

Appeals court rules against health law's contraception rule

News outlets covered the blow to the Obama administration's requirement that insurance policies include free coverage for women's birth control.

4 Nov 2013

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

The U.S. Food and Drug Administration today approved Opsumit (macitentan), a new drug to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive and debilitating disease that can lead to death or the need for lung transplantation.

19 Oct 2013

Results of Phase 3 clinical trial of contraceptive vaginal ring presented by Population Council

Today, the Population Council presented findings from a Phase 3 clinical trial that was designed to demonstrate the safety, efficacy, and acceptability of the Council's investigational one-year contraceptive vaginal ring (CVR).

16 Oct 2013

FDA approves OTREXUP injection for adults with RA, children with active pJIA

Antares Pharma, Inc. today announced the approval of OTREXUP (methotrexate) injection by the U.S. Food and Drug Administration. OTREXUP is the first FDA approved subcutaneous methotrexate for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.

14 Oct 2013

Adempas drug gets FDA approval for treatment of pulmonary hypertension

The U.S. Food and Drug Administration today approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension. Pulmonary hypertension is caused by abnormally high blood pressure in the arteries of the lungs.

10 Oct 2013

Bayer HealthCare receives FDA approval for Adempas tablets

Bayer HealthCare announced today that the United States Food and Drug Administration has approved Adempas (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (WHO Group 4) after surgical treatment or inoperable CTEPH to improve exercise capacity and WHO functional class; and (ii) the treatment of adults with pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity, improve WHO functional class and delay clinical worsening.

9 Oct 2013

Study: Women with eating disorders are less likely to have children

Women with eating disorders are less likely to have children than others in the same age group, indicates a study conducted at the University of Helsinki, Finland. The likelihood for miscarriage was more than triple for binge-eating disorder (BED) sufferers and the likelihood of abortion more than double for bulimics than others in the same age group.

8 Oct 2013

Contraception News and Research

Latest Contraception News and Research

Supreme Court to hear arguments on health law's contraceptive coverage mandate

First Edition: Nov. 27, 2013

Supreme Court mulls taking health law contraception case

UT Austin study reveals gender differences in sexual regret

Contraception coverage, abortion loom as issues for high court and advocacy groups

Gilead Sciences gets marketing authorization from European Commission for Vitekta tablets

Viewpoints: Some who supported health law learning first-hand about the downsides; small businesses not finding better deals; Clinton should know there is no 'magic solution'

In states not expanding Medicaid, hospitals face a squeeze as federal funds dry up

First Edition: November 11, 2013

Viewpoints: Campaigning won't help solve health care problems; health law sought 'sturdier safety net;' court's decision on contraception benefit 'goes wrong way'

New study looks at hormone/SNS relationship in women taking hormone contraceptives

Appeals court decision is latest blow to birth control mandate, setting up possible Supreme Court consideration

First Edition: November 4, 2013

Appeals court rules against health law's contraception rule

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

Results of Phase 3 clinical trial of contraceptive vaginal ring presented by Population Council

FDA approves OTREXUP injection for adults with RA, children with active pJIA

Adempas drug gets FDA approval for treatment of pulmonary hypertension

Bayer HealthCare receives FDA approval for Adempas tablets

Study: Women with eating disorders are less likely to have children

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Contraception News and Research

Latest Contraception News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in